Home / Intelligence / Blog / AI-Based Software Paige Prostate is Granted FDA Approval Through the De Novo Regulatory Pathway
Published September 27, 2021
![](https://trinitylifesciences.com/wp-content/uploads/2021/11/Paige-Cover-Image-1024x673.jpg)
Paige Prostate is the first artificial intelligence (AI)-based software designed to identify areas of concern (i.e., high likelihood of containing cancer) on a prostate biopsy image so they can be flagged for further review by a pathologist. The program is intended to be used as an adjunct tool to the review of digital scanner slide images from prostate biopsies.
The program was reviewed through the De Novo pathway, a regulatory pathway for low-to-moderate risk novel devices. The FDA authorization is based on clinical trial data which suggests improved detection of cancer on slide images by an average of 7.3% with Paige Prostate vs. unassisted examination by pathologists. The program also reduced the number of false-negatives by 70% and false-positives by 24%. This FDA authorization follows Paige AI receiving a CE mark for both its prostate software and its breast cancer product for use in the EU last year.
Paige’s co-founder and chief medical officer, David Klimstra, notes that Paige’s landmark FDA-approval and EU access “marks the beginning of a new era in the use of computer-assisted diagnostics for pathology.”
Written by Crystal Zhao and Kate Watkins
Related Intelligence
Blog
The Next Wave of Global AI Medical Devices: Innovation in Action
A recent bipartisan initiative by Senators Martin Heinrich, Mike Rounds, Marsha Blackburn and Todd Young urged the Centers for Medicare & Medicaid Services (CMS) to establish a formal payment pathway for algorithm-based health care services (ABHS). This move addresses the need for stable Medicare reimbursement for FDA-cleared AI and machine learning (ML) medical devices, which […]
Read More
Webinars
Human Centered Design Approach to GenAI for Life Sciences
Available On Demand
We need to think through not just whether GenAI works, but how we make it usable for people and impactful for our business… The next webinar in our “Making AI Real” webinar series will focus on people, process and technology—three interconnected components that are key to successful GenAI implementation. Join Trinity Life Sciences’ GenAI experts […]
Watch Now
Case Studies
HCP-level Site Alert Predictions
Trinity was able to develop an advanced machine learning algorithm to predict potential site alerts for HCPs in the target universe
Read More